Software - Application
Compare Stocks
5 / 10Stock Comparison
GWRE vs SPNS vs NOW vs VEEV vs PCTY
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Medical - Healthcare Information Services
Software - Application
GWRE vs SPNS vs NOW vs VEEV vs PCTY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Application | Medical - Healthcare Information Services | Software - Application |
| Market Cap | $11.70B | $2.43B | $94.48B | $27.03B | $6.04B |
| Revenue (TTM) | $1.34B | $564M | $13.96B | $3.20B | $1.73B |
| Net Income (TTM) | $189M | $64M | $1.76B | $909M | $258M |
| Gross Margin | 63.8% | 44.3% | 76.6% | 75.5% | 69.3% |
| Operating Margin | 6.8% | 13.7% | 13.4% | 28.7% | 21.3% |
| Forward P/E | 39.4x | 27.9x | 21.9x | 18.8x | 14.3x |
| Total Debt | $716M | $64M | $3.20B | $96M | $218M |
| Cash & Equiv. | $699M | $164M | $3.73B | $1.42B | $398M |
GWRE vs SPNS vs NOW vs VEEV vs PCTY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Guidewire Software,… (GWRE) | 100 | 135.0 | +35.0% |
| Sapiens Internation… (SPNS) | 100 | 184.0 | +84.0% |
| ServiceNow, Inc. (NOW) | 100 | 23.5 | -76.5% |
| Veeva Systems Inc. (VEEV) | 100 | 76.0 | -24.0% |
| Paylocity Holding C… (PCTY) | 100 | 85.4 | -14.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GWRE vs SPNS vs NOW vs VEEV vs PCTY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GWRE is the clearest fit if your priority is growth exposure.
- Rev growth 22.6%, EPS growth 11.9%, 3Y rev CAGR 14.0%
- 22.6% revenue growth vs SPNS's 5.4%
SPNS has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 301.1% 10Y total return vs VEEV's 5.1%
- Lower volatility, beta 0.45, Low D/E 13.3%, current ratio 2.24x
- 1.3% yield; 1-year raise streak; the other 4 pay no meaningful dividend
- +53.4% vs NOW's -90.6%
NOW is the clearest fit if your priority is valuation efficiency.
- PEG 0.32 vs SPNS's 1.40
VEEV is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 28.4% margin vs SPNS's 11.4%
- 11.1% ROA vs PCTY's 4.9%, ROIC 12.9% vs 26.2%
PCTY ranks third and is worth considering specifically for income & stability and defensive.
- beta 0.39
- Beta 0.39, current ratio 1.14x
- Lower P/E (14.3x vs 18.8x), PEG 0.51 vs 1.03
- Beta 0.39 vs NOW's 1.39, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 22.6% revenue growth vs SPNS's 5.4% | |
| Value | Lower P/E (14.3x vs 18.8x), PEG 0.51 vs 1.03 | |
| Quality / Margins | 28.4% margin vs SPNS's 11.4% | |
| Stability / Safety | Beta 0.39 vs NOW's 1.39, lower leverage | |
| Dividends | 1.3% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +53.4% vs NOW's -90.6% | |
| Efficiency (ROA) | 11.1% ROA vs PCTY's 4.9%, ROIC 12.9% vs 26.2% |
GWRE vs SPNS vs NOW vs VEEV vs PCTY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GWRE vs SPNS vs NOW vs VEEV vs PCTY — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PCTY leads in 2 of 6 categories
VEEV leads 1 • SPNS leads 1 • GWRE leads 0 • NOW leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VEEV leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOW is the larger business by revenue, generating $14.0B annually — 24.7x SPNS's $564M. VEEV is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to SPNS's 11.4%. On growth, GWRE holds the edge at +24.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.3B | $564M | $14.0B | $3.2B | $1.7B |
| EBITDAEarnings before interest/tax | $103M | $93M | $2.7B | $956M | $394M |
| Net IncomeAfter-tax profit | $189M | $64M | $1.8B | $909M | $258M |
| Free Cash FlowCash after capex | $310M | $72M | $4.6B | $1.4B | $470M |
| Gross MarginGross profit ÷ Revenue | +63.8% | +44.3% | +76.6% | +75.5% | +69.3% |
| Operating MarginEBIT ÷ Revenue | +6.8% | +13.7% | +13.4% | +28.7% | +21.3% |
| Net MarginNet income ÷ Revenue | +14.1% | +11.4% | +12.6% | +28.4% | +14.9% |
| FCF MarginFCF ÷ Revenue | +23.1% | +12.8% | +33.2% | +43.7% | +27.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +24.0% | +11.2% | +22.1% | +16.0% | +10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | -24.2% | +2.3% | +23.9% | +26.7% |
Valuation Metrics
PCTY leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 27.6x trailing earnings, PCTY trades at a 84% valuation discount to GWRE's 170.9x P/E. Adjusting for growth (PEG ratio), NOW offers better value at 0.79x vs SPNS's 1.69x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11.7B | $2.4B | $94.5B | $27.0B | $6.0B |
| Enterprise ValueMkt cap + debt − cash | $11.7B | $2.3B | $94.0B | $25.7B | $5.9B |
| Trailing P/EPrice ÷ TTM EPS | 170.93x | 33.68x | 54.60x | 30.56x | 27.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 39.38x | 27.85x | 21.94x | 18.76x | 14.29x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.69x | 0.79x | 1.68x | 0.98x |
| EV / EBITDAEnterprise value multiple | 180.79x | 22.11x | 36.67x | 28.05x | 14.51x |
| Price / SalesMarket cap ÷ Revenue | 9.73x | 4.48x | 7.12x | 8.46x | 3.78x |
| Price / BookPrice ÷ Book value/share | 8.16x | 5.09x | 7.36x | 3.85x | 5.09x |
| Price / FCFMarket cap ÷ FCF | 39.66x | 33.63x | 20.65x | 19.10x | 17.61x |
Profitability & Efficiency
PCTY leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
PCTY delivers a 22.4% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $13 for SPNS. VEEV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to GWRE's 0.49x. On the Piotroski fundamental quality scale (0–9), SPNS scores 8/9 vs NOW's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.9% | +12.9% | +15.0% | +13.4% | +22.4% |
| ROA (TTM)Return on assets | +7.2% | +8.9% | +7.5% | +11.1% | +4.9% |
| ROICReturn on invested capital | +2.3% | +17.4% | +12.4% | +12.9% | +26.2% |
| ROCEReturn on capital employed | +2.3% | +16.9% | +13.2% | +13.8% | +23.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 3 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.49x | 0.13x | 0.25x | 0.01x | 0.18x |
| Net DebtTotal debt minus cash | $17M | -$100M | -$523M | -$1.3B | -$180M |
| Cash & Equiv.Liquid assets | $699M | $164M | $3.7B | $1.4B | $398M |
| Total DebtShort + long-term debt | $716M | $64M | $3.2B | $96M | $218M |
| Interest CoverageEBIT ÷ Interest expense | 388.85x | 228.41x | 185.08x | — | 23.29x |
Total Returns (Dividends Reinvested)
SPNS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPNS five years ago would be worth $16,401 today (with dividends reinvested), compared to $1,953 for NOW. Over the past 12 months, SPNS leads with a +53.4% total return vs NOW's -90.6%. The 3-year compound annual growth rate (CAGR) favors SPNS at 26.2% vs NOW's -40.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.2% | — | -38.2% | -24.3% | -23.8% |
| 1-Year ReturnPast 12 months | -35.1% | +53.4% | -90.6% | -30.6% | -42.7% |
| 3-Year ReturnCumulative with dividends | +78.2% | +100.9% | -79.2% | -6.3% | -36.1% |
| 5-Year ReturnCumulative with dividends | +41.7% | +64.0% | -80.5% | -33.3% | -31.8% |
| 10-Year ReturnCumulative with dividends | +149.8% | +301.1% | +35.2% | +512.1% | +223.7% |
| CAGR (3Y)Annualised 3-year return | +21.2% | +26.2% | -40.8% | -2.2% | -13.8% |
Risk & Volatility
Evenly matched — SPNS and PCTY each lead in 1 of 2 comparable metrics.
Risk & Volatility
PCTY is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than NOW's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPNS currently trades 99.8% from its 52-week high vs NOW's 8.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.50x | 0.45x | 1.39x | 0.72x | 0.39x |
| 52-Week HighHighest price in past year | $272.60 | $43.52 | $1057.39 | $310.50 | $201.97 |
| 52-Week LowLowest price in past year | $115.57 | $26.14 | $81.24 | $148.05 | $92.99 |
| % of 52W HighCurrent price vs 52-week peak | +50.8% | +99.8% | +8.6% | +53.5% | +54.9% |
| RSI (14)Momentum oscillator 0–100 | 49.7 | 69.6 | 48.0 | 50.6 | 55.2 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 0 | 21.1M | 2.3M | 736K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GWRE as "Buy", SPNS as "Hold", NOW as "Buy", VEEV as "Buy", PCTY as "Buy". Consensus price targets imply 77.1% upside for GWRE (target: $245) vs -12.5% for SPNS (target: $38). SPNS is the only dividend payer here at 1.30% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $245.17 | $38.00 | $154.08 | $280.10 | $147.73 |
| # AnalystsCovering analysts | 26 | 10 | 68 | 42 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — | — |
| Dividend / ShareAnnual DPS | — | $0.57 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.9% | +0.6% | +2.5% |
PCTY leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). VEEV leads in 1 (Income & Cash Flow). 1 tied.
GWRE vs SPNS vs NOW vs VEEV vs PCTY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GWRE or SPNS or NOW or VEEV or PCTY a better buy right now?
For growth investors, Guidewire Software, Inc.
(GWRE) is the stronger pick with 22. 6% revenue growth year-over-year, versus 5. 4% for Sapiens International Corporation N. V. (SPNS). Paylocity Holding Corporation (PCTY) offers the better valuation at 27. 6x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate Guidewire Software, Inc. (GWRE) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GWRE or SPNS or NOW or VEEV or PCTY?
On trailing P/E, Paylocity Holding Corporation (PCTY) is the cheapest at 27.
6x versus Guidewire Software, Inc. at 170. 9x. On forward P/E, Paylocity Holding Corporation is actually cheaper at 14. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ServiceNow, Inc. wins at 0. 32x versus Sapiens International Corporation N. V. 's 1. 40x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GWRE or SPNS or NOW or VEEV or PCTY?
Over the past 5 years, Sapiens International Corporation N.
V. (SPNS) delivered a total return of +64. 0%, compared to -80. 5% for ServiceNow, Inc. (NOW). Over 10 years, the gap is even starker: VEEV returned +512. 1% versus NOW's +35. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GWRE or SPNS or NOW or VEEV or PCTY?
By beta (market sensitivity over 5 years), Paylocity Holding Corporation (PCTY) is the lower-risk stock at 0.
39β versus ServiceNow, Inc. 's 1. 39β — meaning NOW is approximately 255% more volatile than PCTY relative to the S&P 500. On balance sheet safety, Veeva Systems Inc. (VEEV) carries a lower debt/equity ratio of 1% versus 49% for Guidewire Software, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GWRE or SPNS or NOW or VEEV or PCTY?
By revenue growth (latest reported year), Guidewire Software, Inc.
(GWRE) is pulling ahead at 22. 6% versus 5. 4% for Sapiens International Corporation N. V. (SPNS). On earnings-per-share growth, the picture is similar: Guidewire Software, Inc. grew EPS 1192% year-over-year, compared to 10. 7% for Paylocity Holding Corporation. Over a 3-year CAGR, PCTY leads at 23. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GWRE or SPNS or NOW or VEEV or PCTY?
Veeva Systems Inc.
(VEEV) is the more profitable company, earning 28. 4% net margin versus 5. 8% for Guidewire Software, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus 3. 4% for GWRE. At the gross margin level — before operating expenses — NOW leads at 77. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GWRE or SPNS or NOW or VEEV or PCTY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ServiceNow, Inc. (NOW) is the more undervalued stock at a PEG of 0. 32x versus Sapiens International Corporation N. V. 's 1. 40x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Paylocity Holding Corporation (PCTY) trades at 14. 3x forward P/E versus 39. 4x for Guidewire Software, Inc. — 25. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GWRE: 77. 1% to $245. 17.
08Which pays a better dividend — GWRE or SPNS or NOW or VEEV or PCTY?
In this comparison, SPNS (1.
3% yield) pays a dividend. GWRE, NOW, VEEV, PCTY do not pay a meaningful dividend and should not be held primarily for income.
09Is GWRE or SPNS or NOW or VEEV or PCTY better for a retirement portfolio?
For long-horizon retirement investors, Sapiens International Corporation N.
V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), 1. 3% yield, +301. 1% 10Y return). Both have compounded well over 10 years (SPNS: +301. 1%, NOW: +35. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GWRE and SPNS and NOW and VEEV and PCTY?
These companies operate in different sectors (GWRE (Technology) and SPNS (Technology) and NOW (Technology) and VEEV (Healthcare) and PCTY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GWRE is a mid-cap high-growth stock; SPNS is a small-cap quality compounder stock; NOW is a mid-cap high-growth stock; VEEV is a mid-cap high-growth stock; PCTY is a small-cap quality compounder stock. SPNS pays a dividend while GWRE, NOW, VEEV, PCTY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.